Bicara Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -19 | |||
EBITDA | -60,242 | -41,122 | -36,234 | -31,999 |
EBIT | -41,133 | -36,290 | -32,018 | |
Net Income | -56,211 | -37,386 | -36,330 | -27,388 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -37,568 | -24,124 | -29,290 | -25,594 |
Cash | 323,462 | 96,685 | 171,673 | 436,606 |
Basic Shares | 60,717 | 55,142 | 54,563 | 54,539 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -56 | -19 | -10 | |
EBITDA | -155,604 | -82,333 | -39,870 | -37,722 |
EBIT | -155,709 | -82,389 | -39,889 | -37,732 |
Net Income | -137,950 | -67,995 | -51,985 | -37,845 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -107,114 | -74,822 | -46,214 | -32,268 |
Cash | 96,685 | 489,711 | 230,440 | 4,158 |
Basic Shares | 54,676 | 54,424 | 51,760 | 51,760 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.93 |
2025-12-31 | -$0.68 |
2025-09-30 | -$0.67 |
2025-06-30 | -$0.50 |